Mitochondrial Dysfunction and Cellular Senescence Drive Preterm Birth

Spontaneous preterm birth (sPTB) affects roughly 10% of all live births globally — approximately 15 million infants annually — and remains the leading cause of neonatal mortality and long-term childhood morbidity. Despite decades of research, incidence rates have barely shifted, partly because infection-centric models fail to explain many cases. This 2026 narrative review, published in Apoptosis by researchers at Manipal Academy of Higher Education, proposes a unifying framework: sPTB as accelerated gestational aging, driven at the molecular level by mitochondrial dysfunction and cellular senescence.

The authors synthesized literature from PubMed/MEDLINE covering mitochondrial biology, oxidative stress, senescence, and related signalling pathways in gestational tissues. They argue that the molecular changes normally orchestrating term labour — oxidative stress, inflammatory signalling, extracellular matrix (ECM) degradation, and tissue senescence — are prematurely activated in sPTB. Across five key compartments (placenta, fetal membranes, decidua, cervix, myometrium), tissue-specific stress responses converge on shared pathological endpoints.

In the placenta and fetal membranes, mitochondrial oxidative phosphorylation (OXPHOS) is impaired, ROS generation rises, and biogenesis regulators such as PGC-1α and TFAM are downregulated. This yields elevated lipid peroxidation products and protein carbonyls. Damaged mitochondria release DAMPs — including mitochondrial DNA (mtDNA), cardiolipin, and TFAM — that activate TLR9 and the NLRP3 inflammasome, generating sterile inflammation even without microbial infection. Elevated cell-free mtDNA in maternal plasma and amniotic fluid has been identified as a potential biomarker, particularly in preterm premature rupture of membranes (PPROM).

Senescent amnion and chorion cells develop SASP, secreting inflammatory cytokines, matrix metalloproteinases, and DAMPs that degrade ECM, weaken fetal membranes, and activate adjacent tissues. The review integrates several underexplored amplifying mechanisms: ferroptosis (iron-dependent lipid peroxidative cell death) compounds ROS-driven injury; NAD⁺ depletion impairs cellular energy homeostasis and senescence surveillance; LINE1 retrotransposon derepression following heterochromatin erosion propagates inflammatory signalling; and extracellular vesicles shuttle senescence and inflammatory signals across the maternal-fetal interface. Environmental exposures, notably PM2.5 air pollution and heat stress, serve as upstream triggers of placental mitochondrial dysfunction, linking population-level risk factors to the molecular cascade.

Therapeutically, the authors highlight mitochondrial-targeted antioxidants (e.g., MitoQ), senolytic agents (eliminating senescent cells), and NLRP3 inflammasome inhibitors as candidates warranting clinical investigation. Multi-marker biomarker panels integrating mtDNA, SASP cytokines, and oxidative stress indices are proposed for improved risk stratification. The authors acknowledge that this is a narrative rather than systematic review, limiting formal evidence grading, and that much mechanistic evidence derives from animal models or in vitro studies with uncertain translational fidelity. Nevertheless, the framework offers a compelling integrative model that could guide precision-based preventive strategies against prematurity.